Anavex Compound to be Tested in Biogen Neurological Protection Model
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 1.31 +0.03 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.28 | 52 Week High | $8.30 | |||
| Open | $1.28 | 52 Week Low | $2.43 | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $-0.22 | |||
| Volume | 1,351,029 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 252.73 +0.47 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $252.26 | 52 Week High | $333.65 | |||
| Open | $250.35 | 52 Week Low | $223.02 | |||
| Day High | $253.98 | P/E | 32.36 | |||
| Day Low | $248.46 | EPS | $7.81 | |||
| Volume | 1,393,389 | |||||
